Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoresis of sodium nitroprusside for digital ischaemia in scleroderma-spectrum disorders
2004-002799-41Phase 2Completed
- Sponsor
- Northern Care Alliance
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium nitroprusside in systemic sclerosis (SSc) and Scleroderma-spectrum disorder (SSD), sponsored by Northern Care Alliance. Primary endpoint: Increase in perfusion. Started Jun 2005; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
systemic sclerosis (SSc)Scleroderma-spectrum disorder (SSD)
Beyond the preview
Go deeper on 2004-002799-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002799-41.